French scientists have created a life-prolonging medicine
French scientists have created a drug alirocoumab, which reduces the level of "bad" cholesterol in the blood and reduces the risk of stroke and heart attack by 15 percent. This is reported in a press release on MedicalXpress.
It is shown that alirocoumab also significantly increases life expectancy, reducing the risk of premature death. It belongs to the class of inhibitors of PCSK9, which are monoclonal antibodies that cause an attack of the immune system on a specific protein in the liver, responsible for the production of low density lipoprotein (LDL). In people with a high level of "bad" cholesterol, the risk of premature death was reduced by 29 percent after taking the drug for two years.
Cholesterol - fatty alcohol, which is contained in the blood in the form of lipoproteins of various types. Lipoproteins of low density can block narrow vessels, causing disturbances in the cardiovascular system. Cholesterol, which is in their composition, is called "bad." High-density lipoproteins (HDL) are carriers of "good" cholesterol, which helps reduce the risk of atherosclerosis, stroke and heart attack.